BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Darlifarnib readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Darlifarnib\, from ClinicalTrials.gov est
 imates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06026410-2447@assetmemo.bio
DTSTAMP:20261121T005833Z
DTSTART;VALUE=DATE:20270131
DTEND;VALUE=DATE:20270201
SUMMARY:Darlifarnib: Phase 1 readout est. (NCT06026410)
DESCRIPTION:Darlifarnib\, phase 1\, Non-Small Cell Lung Cancer.\nStudy: KO-
 2806 Monotherapy and Combination Therapies in Advanced Solid Tumors\nEstim
 ated primary completion: January 2027. This is a ClinicalTrials.gov estima
 te\, not a confirmed readout date\, and it can move.\nDrug page: https://a
 ssetmemo.bio/drug/darlifarnib#upcoming-events\nRegistry record: https://cl
 inicaltrials.gov/study/NCT06026410
URL:https://assetmemo.bio/drug/darlifarnib#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
